Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

Possibly Marketed Outside US

1

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

2005

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

1

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

1

CHEBI

1

DAILYMED

1

DRUG BANK

1

DRUG CENTRAL

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

ALIMENTARY TRACT AND METABOLISM

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

LAXATIVES

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

LAXATIVES

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Osmotically acting laxatives

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

1

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 1 of 1 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

PENTAERYTHRITOL

SU420W1S6N

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 2005

Class (Stereo):

CHEMICAL (ACHIRAL)

Pentaerythritol is an inactive metabolite of pentaerythritol tetranitrate, a drug that is used for the treatment of angina pectoris.

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1